Coronavirus disease 2019 (COVID-19) : frequently asked questions
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Coronavirus disease 2019 (COVID-19) : frequently asked questions
Filetype[PDF-216.07 KB]


Details:
    1. Filetype[PDF - 65.84 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 21, 2020
      Series:
      Coronavirus Disease 2019 (COVID-19)
      Description:
      There are no US Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19. At present clinical management includes infection prevention and control measures and supportive care, including supplementary...
      File Type:
      Filetype[PDF - 65.84 KB]
    2. Filetype[PDF - 517.96 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 20, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      Updated March 20, 2020This page will be updated regularly at noon Mondays through Fridays. Numbers close out at 4 p.m. the day before reporting.CDC is responding to an outbreak of respiratory illness caused by a novel (new) coronavirus. The outbreak ...
      File Type:
      Filetype[PDF - 517.96 KB]
    3. Filetype[PDF - 542.80 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 20, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      This page will be updated regularly at noon Mondays through Fridays. Data close out at 4 p.m. the day before reporting.CDC is responding to an outbreak of respiratory illness caused by a novel (new) coronavirus. The outbreak first started in Wuhan, C...
      File Type:
      Filetype[PDF - 542.80 KB]
    4. Filetype[PDF - 539.17 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 21, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      File Type:
      Filetype[PDF - 539.17 KB]
    5. Filetype[PDF - 832.93 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      18//03/2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      CDC protects and prepares communities [Vietnamese]CDC đang quyết liệt ứng phó với sự bùng phát toàn cầu của COVID-19 và sự lây lan trong cộng đồng tại Hoa Kỳ.cdc.gov/COVID19CS 315454-AMP_infographic-cd...
      File Type:
      Filetype[PDF - 832.93 KB]
    6. Filetype[PDF - 822.75 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      03/18/2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      CDC protects and prepares communities [Spanish]Los CDC están respondiendo enérgicamente al brote mundial de COVID-19 y su propagación comunitaria en EE. UUcdc.gov/COVID19CS 315454-AMP_infographic-cdc-protects-508_spa.pdf
      File Type:
      Filetype[PDF - 822.75 KB]
    7. Filetype[PDF - 884.64 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      03/18/2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      CDC protects and prepares communities [Chinese]CDC正在积极应对全球COVID-19的爆发以及美国境内的社区传播。cdc.gov/COVID19CS 315454-Adownloads/MP_infographic-cdc-protects-508_zho-CN.pdf
      File Type:
      Filetype[PDF - 884.64 KB]
    8. Filetype[PDF - 835.13 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      03/18/2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      CDC protects and prepares communities [Korean]CDC is aggressively responding to the global outbreak of COVID-19 and community spread in the U.S. [Korean}cdc.gov/COVID19CS 315454-AMP_infographic-cdc-protects-508_kor.pdf
      File Type:
      Filetype[PDF - 835.13 KB]
    9. Filetype[PDF - 224.26 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 20, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      File Type:
      Filetype[PDF - 224.26 KB]
    10. Filetype[PDF - 813.54 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      03/18/2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      CDC is aggressively responding to the global outbreak of COVID-19 and community spread in the U.S.cdc.gov/COVID19CS 315454-Ainfographic-cdc-protects-508.pdf
      File Type:
      Filetype[PDF - 813.54 KB]
    11. Filetype[PDF - 346.12 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 21, 2020
      Series:
      Coronavirus Disease 2019 (COVID-19)
      Description:
      This is an emerging, rapidly evolving situation and CDC will provide updated information as it becomes available, in addition to updated guidance.Updated March 21, 2020CDC is responding to a pandemic of respiratory disease spreading from person-to-pe...
      File Type:
      Filetype[PDF - 346.12 KB]
    12. Filetype[PDF - 539.17 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 21, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      This page will be updated regularly at noon Mondays through Fridays. Data close out at 4 p.m. the day before reporting.CDC is responding to an outbreak of respiratory illness caused by a novel (new) coronavirus. The outbreak first started in Wuhan, C...
      File Type:
      Filetype[PDF - 539.17 KB]
    13. Filetype[PDF - 170.47 KB]
      Corporate Authors:
      United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health.. SRC, Inc..
      Published Date:
      February 2020
      Series:
      ToxFAQs
      Description:
      2-Hexanone is also known as methyl n-butyl ketone, MBK, or propyl acetone. It is a clear, colorless liquid with a sharp odor. It dissolves very easily in water and can evaporate easily into the air as a vapor.It is formed as a waste product resulting...
      File Type:
      Filetype[PDF - 170.47 KB]
    14. Filetype[PDF - 178.71 KB]
      Corporate Authors:
      United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health.. SRC, Inc..
      Published Date:
      Septiembre 1995
      Series:
      ToxFAQs
      Description:
      2-Hexanone - ToxFAQs [Spanish]La 2-hexanona se conoce también como metil n-butil cetona (MBK) o propil acetona. Es un líquido incoloro de aroma penetrante. Se disuelve fácilmente en el agua, y se evapora fácilmente al aire.La 2-hexanona se usó e...
      File Type:
      Filetype[PDF - 178.71 KB]

You May Also Like:

  1. Filetype[PDF - 266.89 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    March 12, 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Who this is for: Pediatric Healthcare ProvidersWhat this is for: To inform pediatric healthcare providers of information available on children with COVID-19.How to use: Refer to this information when managing pediatric patients with confirmed or susp...
    File Type:
    Filetype[PDF - 266.89 KB]
  2. Filetype[PDF - 110.53 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    April 14, 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    File Type:
    Filetype[PDF - 110.53 KB]
  3. Filetype[PDF - 469.23 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    April 17 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    This page will be updated daily. Numbers close out at 4 p.m. the day before reporting.CDC is responding to an outbreak of respiratory illness caused by a novel (new) coronavirus. The outbreak first started in Wuhan, China, but cases have been identif...
    File Type:
    Filetype[PDF - 469.23 KB]
  4. Filetype[PDF - 101.44 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    April 16, 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    The data on this page was collected earlier in the U.S. COVID-19 outbreak. Due to the ongoing community spread of the virus, this information is no longer relevant to understanding the current situation. This information was last updated on April 16,...
    File Type:
    Filetype[PDF - 101.44 KB]
  5. Filetype[PDF - 436.52 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    April 16 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Updated April 16, 2020This page will be updated regularly at noon Mondays through Fridays. Numbers close out at 4 p.m. the day before reporting.CDC is responding to an outbreak of respiratory illness caused by a novel (new) coronavirus. The outbreak ...
    File Type:
    Filetype[PDF - 436.52 KB]